These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27601163)

  • 21. Mastermind-like Transcriptional Coactivator 1 Overexpression Predicts Poor Prognosis in Human with Hepatocellular Carcinoma.
    Wang J; Zhang SM; Wu JM; Lu ZC; Yang JR; Wu HS; Chen H; Lin B; Xu RH; Cao TS
    Ann Clin Lab Sci; 2016 Sep; 46(5):502-7. PubMed ID: 27650617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
    Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from HBV-related hepatocellular carcinoma.
    Yang Z; Zhuang L; Yu Y; Zhou W; Lu Y; Xu Q; Tang B; Chen X
    Discov Med; 2015 Dec; 20(112):349-56. PubMed ID: 26760979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
    Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
    Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis.
    Tang L; Liu JX; Zhang ZJ; Xu CZ; Zhang XN; Huang WR; Zhou DH; Wang RR; Chen XD; Xiao MB; Qu LS; Lu CH
    Pathol Res Pract; 2019 Jun; 215(6):152386. PubMed ID: 30935762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
    Fu YP; Yi Y; Cai XY; Sun J; Ni XC; He HW; Wang JX; Lu ZF; Huang JL; Cao Y; Zhou J; Fan J; Qiu SJ
    Br J Cancer; 2016 Mar; 114(7):767-76. PubMed ID: 27002937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma.
    Zheng H; Jiang WH; Tian T; Tan HS; Chen Y; Qiao GL; Han J; Huang SY; Yang Y; Li S; Wang ZG; Gao R; Ren H; Xing H; Ni JS; Wang LH; Ma LJ; Zhou WP
    Oncotarget; 2017 Mar; 8(12):18872-18884. PubMed ID: 28122351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ; Fu ZQ; Gong H
    World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
    Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
    Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
    Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
    Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.
    Liu F; Lv H; Jia X; Liu G; Li T; Xu Z; Li J
    J Surg Oncol; 2014 Aug; 110(2):151-5. PubMed ID: 24634224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
    Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
    Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of CLN3 contributes to tumour progression and predicts poor prognosis in hepatocellular carcinoma.
    Xu Y; Wang H; Zeng Y; Tian Y; Shen Z; Xie Z; Chen F; Sun L; Shu R; Li PP; Chen C; Yu J; Wang K; Luo H
    Surg Oncol; 2019 Mar; 28():180-189. PubMed ID: 30851897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DHX33 expression is increased in hepatocellular carcinoma and indicates poor prognosis.
    Tian QH; Zhang MF; Luo RG; Fu J; He C; Hu G; Zeng JS
    Biochem Biophys Res Commun; 2016 May; 473(4):1163-1169. PubMed ID: 27073163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importin-α1 as a novel prognostic target for hepatocellular carcinoma.
    Yoshitake K; Tanaka S; Mogushi K; Aihara A; Murakata A; Matsumura S; Mitsunori Y; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
    Ann Surg Oncol; 2011 Jul; 18(7):2093-103. PubMed ID: 21286940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.